Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India

por Khobragade, Akash, Bhate, Suresh, Ramaiah, Vijendra, Deshpande, Shrikant, Giri, Krishna, Phophle, Himanshu, Supe, Pravin, Godara, Inderjeet, Revanna, Ramesh, Nagarkar, Rajnish, Sanmukhani, Jayesh, Dey, Ayan, Rajanathan, T M Chozhavel, Kansagra, Kevinkumar, Koradia, Parshottam
Publicado 2022